Literature DB >> 10935859

Cerebellar ataxia, hypogonadism and chorioretinopathy: molecular analysis of an Italian family.

R Rizzi1, V Carelli, L Monari, M Mochi, R Liguori, M Sensi, S Cocozza, A Filla, P Montagna.   

Abstract

This study aimed to determine if cerebellar ataxia, hypogonadism and chorioretinopathy (AHCR) is associated with mutations in mitochondrial DNA or in genes responsible for spinocerebellar ataxias (SCA1, SCA2, SCA3 and Friedreich's ataxia). Two brothers with cerebellar ataxia, hypogonadism and chorioretinopathy and their unaffected parents underwent molecular analysis for duplications and deletions in mitochondrial DNA (mtDNA), point mutations in the ATP ase 6 gene, and expansions of CAG repeats (at 6p22-p23, 12q24.1, 14q32.1) and of GAA repeats (at gene X25 on chromosome 9q13). The research was negative for all mutations. Our findings confirm that AHCR is a distinct disease within the inherited cerebellar ataxias.

Entities:  

Mesh:

Year:  1998        PMID: 10935859     DOI: 10.1007/BF03028811

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  14 in total

1.  Familial ataxia, hypogonadism and retinal degeneration.

Authors:  B J Boucher; F B Gibberd
Journal:  Acta Neurol Scand       Date:  1969       Impact factor: 3.209

2.  Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2.

Authors:  S M Pulst; A Nechiporuk; T Nechiporuk; S Gispert; X N Chen; I Lopes-Cendes; S Pearlman; S Starkman; G Orozco-Diaz; A Lunkes; P DeJong; G A Rouleau; G Auburger; J R Korenberg; C Figueroa; S Sahba
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

3.  Spinocerebellar ataxia, hypogonadotropic hypogonadism, and choroidal dystrophy (Boucher-Neuhäuser syndrome)

Authors:  E R Limber; G H Bresnick; R M Lebovitz; R E Appen; E F Gilbert-Barness; R M Pauli
Journal:  Am J Med Genet       Date:  1989-07

4.  The gene for autosomal dominant cerebellar ataxia with pigmentary macular dystrophy maps to chromosome 3p12-p21.1.

Authors:  A Benomar; L Krols; G Stevanin; G Cancel; E LeGuern; G David; H Ouhabi; J J Martin; A Dürr; A Zaim
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

Review 5.  The genetic basis of ataxia.

Authors:  R N Rosenberg
Journal:  Clin Neurosci       Date:  1995

6.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1.

Authors:  H T Orr; M Y Chung; S Banfi; T J Kwiatkowski; A Servadio; A L Beaudet; A E McCall; L A Duvick; L P Ranum; H Y Zoghbi
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

7.  Autosomal-dominant cerebellar ataxia with retinal degeneration (ADCA type II) is genetically different from ADCA type I.

Authors:  A Benomar; E Le Guern; A Dürr; H Ouhabi; G Stevanin; M Yahyaoui; T Chkili; Y Agid; A Brice
Journal:  Ann Neurol       Date:  1994-04       Impact factor: 10.422

8.  Syndrome of cerebellar ataxia and hypogonadotrophic hypogonadism: evidence for pituitary gonadotrophin deficiency.

Authors:  A C Fok; M C Wong; J S Cheah
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

9.  The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia.

Authors:  A Filla; G De Michele; F Cavalcanti; L Pianese; A Monticelli; G Campanella; S Cocozza
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

10.  Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.

Authors:  V Campuzano; L Montermini; M D Moltò; L Pianese; M Cossée; F Cavalcanti; E Monros; F Rodius; F Duclos; A Monticelli; F Zara; J Cañizares; H Koutnikova; S I Bidichandani; C Gellera; A Brice; P Trouillas; G De Michele; A Filla; R De Frutos; F Palau; P I Patel; S Di Donato; J L Mandel; S Cocozza; M Koenig; M Pandolfo
Journal:  Science       Date:  1996-03-08       Impact factor: 47.728

View more
  1 in total

1.  Compound heterozygous PNPLA6 mutations cause Boucher-Neuhäuser syndrome with late-onset ataxia.

Authors:  A Deik; B Johannes; J C Rucker; E Sánchez; S E Brodie; E Deegan; K Landy; Y Kajiwara; S Scelsa; R Saunders-Pullman; C Paisán-Ruiz
Journal:  J Neurol       Date:  2014-09-30       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.